Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)]
Volume: 9 Issue: 3
Author(s): Ilka Nemere
Affiliation:
Export Options
About this article
Cite this article as:
Nemere Ilka, Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)], Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2009; 9 (3) . https://dx.doi.org/10.2174/187152209789760468
DOI https://dx.doi.org/10.2174/187152209789760468 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
11
Related Articles
-
DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients
Current Pharmaceutical Design Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer
Current Medicinal Chemistry Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets The Role of the Complex USP1/WDR48 in Differentiation and Proliferation Processes in Cancer Stem Cells
Current Stem Cell Research & Therapy The Role of Culture and Ethnicity in the Adjustment to Gynecological Cancer
Current Women`s Health Reviews Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Biological Activity of Carotenoids: Its Implications in Cancer Risk and Prevention
Current Pharmaceutical Biotechnology The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
Current Drug Targets MicroRNA-155 Functions as a Negative Regulator of RhoA Signaling in TGF-β-induced Endothelial to Mesenchymal Transition
MicroRNA Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Recent Patents in Circulating Cell-Free Tumor DNA as Biomarker in Cancer
Recent Patents on Biomarkers Imaging Studies in Hypercalcemia
Current Medicinal Chemistry Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science